"cdm_name","result_type","group_name","group_level","strata_name","strata_level","variable","variable_level","variable_type","estimate_type","estimate"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Number subjects",NA,"numeric","count","235"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Number records",NA,NA,"count","235"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Cohort start date",NA,"date","min","2012-01-04"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Cohort start date",NA,"date","q05","2012-02-09"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Cohort start date",NA,"date","q25","2013-01-19"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Cohort start date",NA,"date","median","2014-11-25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Cohort start date",NA,"date","q75","2017-01-06"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Cohort start date",NA,"date","q95","2021-01-19"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Cohort start date",NA,"date","max","2022-10-18"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Cohort end date",NA,"date","min","2012-07-07"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Cohort end date",NA,"date","q05","2014-02-24"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Cohort end date",NA,"date","q25","2018-06-10"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Cohort end date",NA,"date","median","2022-12-23"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Cohort end date",NA,"date","q75","2023-11-25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Cohort end date",NA,"date","q95","2024-01-09"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Cohort end date",NA,"date","max","2024-01-16"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Sex","Female","categorical","count","69"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Sex","Female","categorical","percentage","29.3617021276596"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Sex","Male","categorical","count","166"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Sex","Male","categorical","percentage","70.6382978723404"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Age",NA,"numeric","min","18"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Age",NA,"numeric","q05","28"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Age",NA,"numeric","q25","44.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Age",NA,"numeric","median","52"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Age",NA,"numeric","q75","63"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Age",NA,"numeric","q95","75"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Age",NA,"numeric","max","91"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Age",NA,"numeric","mean","52.7702127659574"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Age",NA,"numeric","sd","14.2291369976583"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Prior observation",NA,"numeric","min","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Prior observation",NA,"numeric","q05","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Prior observation",NA,"numeric","q25","93.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Prior observation",NA,"numeric","median","1785"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Prior observation",NA,"numeric","q75","2936.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Prior observation",NA,"numeric","q95","4587.6"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Prior observation",NA,"numeric","max","5866"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Prior observation",NA,"numeric","mean","1810.6"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Prior observation",NA,"numeric","sd","1618.18684065903"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Future observation",NA,"numeric","min","63"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Future observation",NA,"numeric","q05","121.7"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Future observation",NA,"numeric","q25","802.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Future observation",NA,"numeric","median","2125"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Future observation",NA,"numeric","q75","3233.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Future observation",NA,"numeric","q95","4235.9"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Future observation",NA,"numeric","max","4395"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Future observation",NA,"numeric","mean","2057.96595744681"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Future observation",NA,"numeric","sd","1398.35796825532"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Comorbidities flag from -365 to 0","Cirrhosis","binary","count","29"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Comorbidities flag from -365 to 0","Cirrhosis","binary","percentage","12.3404255319149"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Comorbidities flag from -365 to 0","Cardiodisorder","binary","count","76"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Comorbidities flag from -365 to 0","Cardiodisorder","binary","percentage","32.3404255319149"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Comorbidities flag from -365 to 0","Alcoholism","binary","count","18"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Comorbidities flag from -365 to 0","Alcoholism","binary","percentage","7.65957446808511"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Comorbidities flag from -365 to 0","Stds","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Comorbidities flag from -365 to 0","Stds","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Comorbidities flag from -365 to 0","Hypertension","binary","count","35"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Comorbidities flag from -365 to 0","Hypertension","binary","percentage","14.8936170212766"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Comorbidities flag from -365 to 0","Hiv","binary","count","12"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Comorbidities flag from -365 to 0","Hiv","binary","percentage","5.1063829787234"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Comorbidities flag from -365 to 0","Kidneydisease","binary","count","7"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Comorbidities flag from -365 to 0","Kidneydisease","binary","percentage","2.97872340425532"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Comorbidities flag from -365 to 0","Diabetes","binary","count","25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Comorbidities flag from -365 to 0","Diabetes","binary","percentage","10.6382978723404"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Comorbidities flag from -365 to 0","Fattyliver","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","Overall","Overall","Comorbidities flag from -365 to 0","Fattyliver","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Number subjects",NA,"numeric","count","59"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Number records",NA,NA,"count","59"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Cohort start date",NA,"date","min","2012-01-10"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Cohort start date",NA,"date","q05","2012-01-24"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Cohort start date",NA,"date","q25","2012-08-30"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Cohort start date",NA,"date","median","2014-08-26"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Cohort start date",NA,"date","q75","2016-07-14"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Cohort start date",NA,"date","q95","2017-12-17"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Cohort start date",NA,"date","max","2022-10-18"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Cohort end date",NA,"date","min","2014-01-15"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Cohort end date",NA,"date","q05","2015-03-04"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Cohort end date",NA,"date","q25","2019-07-23"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Cohort end date",NA,"date","median","2023-07-29"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Cohort end date",NA,"date","q75","2023-12-13"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Cohort end date",NA,"date","q95","2024-01-07"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Cohort end date",NA,"date","max","2024-01-16"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Sex","Female","categorical","count","20"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Sex","Female","categorical","percentage","33.8983050847458"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Sex","Male","categorical","count","39"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Sex","Male","categorical","percentage","66.1016949152542"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Age",NA,"numeric","min","18"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Age",NA,"numeric","q05","23.9"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Age",NA,"numeric","q25","30"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Age",NA,"numeric","median","34"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Age",NA,"numeric","q75","40"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Age",NA,"numeric","q95","42.1"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Age",NA,"numeric","max","44"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Age",NA,"numeric","mean","33.9830508474576"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Age",NA,"numeric","sd","6.43934973538566"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Prior observation",NA,"numeric","min","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Prior observation",NA,"numeric","q05","0.9"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Prior observation",NA,"numeric","q25","66.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Prior observation",NA,"numeric","median","1282"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Prior observation",NA,"numeric","q75","2422.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Prior observation",NA,"numeric","q95","3654.9"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Prior observation",NA,"numeric","max","4640"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Prior observation",NA,"numeric","mean","1334.18644067797"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Prior observation",NA,"numeric","sd","1318.0457644006"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Future observation",NA,"numeric","min","78"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Future observation",NA,"numeric","q05","205.9"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Future observation",NA,"numeric","q25","1440"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Future observation",NA,"numeric","median","2528"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Future observation",NA,"numeric","q75","3806"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Future observation",NA,"numeric","q95","4248.4"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Future observation",NA,"numeric","max","4363"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Future observation",NA,"numeric","mean","2468.67796610169"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Future observation",NA,"numeric","sd","1333.30286598251"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Comorbidities flag from -365 to 0","Cirrhosis","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Comorbidities flag from -365 to 0","Cirrhosis","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Comorbidities flag from -365 to 0","Cardiodisorder","binary","count","10"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Comorbidities flag from -365 to 0","Cardiodisorder","binary","percentage","16.9491525423729"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Comorbidities flag from -365 to 0","Alcoholism","binary","count","5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Comorbidities flag from -365 to 0","Alcoholism","binary","percentage","8.47457627118644"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Comorbidities flag from -365 to 0","Stds","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Comorbidities flag from -365 to 0","Stds","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Comorbidities flag from -365 to 0","Hypertension","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Comorbidities flag from -365 to 0","Hypertension","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Comorbidities flag from -365 to 0","Hiv","binary","count","7"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Comorbidities flag from -365 to 0","Hiv","binary","percentage","11.864406779661"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Comorbidities flag from -365 to 0","Kidneydisease","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Comorbidities flag from -365 to 0","Kidneydisease","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Comorbidities flag from -365 to 0","Diabetes","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Comorbidities flag from -365 to 0","Diabetes","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Comorbidities flag from -365 to 0","Fattyliver","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","18 to 44","Comorbidities flag from -365 to 0","Fattyliver","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Number subjects",NA,"numeric","count","124"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Number records",NA,NA,"count","124"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Cohort start date",NA,"date","min","2012-01-04"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Cohort start date",NA,"date","q05","2012-02-03"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Cohort start date",NA,"date","q25","2013-01-20"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Cohort start date",NA,"date","median","2014-04-06"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Cohort start date",NA,"date","q75","2016-10-18"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Cohort start date",NA,"date","q95","2020-11-27"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Cohort start date",NA,"date","max","2022-08-29"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Cohort end date",NA,"date","min","2012-07-07"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Cohort end date",NA,"date","q05","2013-08-25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Cohort end date",NA,"date","q25","2018-01-19"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Cohort end date",NA,"date","median","2022-10-21"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Cohort end date",NA,"date","q75","2023-12-01"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Cohort end date",NA,"date","q95","2024-01-08"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Cohort end date",NA,"date","max","2024-01-16"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Sex","Female","categorical","count","39"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Sex","Female","categorical","percentage","31.4516129032258"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Sex","Male","categorical","count","85"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Sex","Male","categorical","percentage","68.5483870967742"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Age",NA,"numeric","min","45"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Age",NA,"numeric","q05","46"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Age",NA,"numeric","q25","48.75"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Age",NA,"numeric","median","53"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Age",NA,"numeric","q75","59"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Age",NA,"numeric","q95","63"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Age",NA,"numeric","max","64"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Age",NA,"numeric","mean","53.8306451612903"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Age",NA,"numeric","sd","5.67654104887562"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Prior observation",NA,"numeric","min","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Prior observation",NA,"numeric","q05","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Prior observation",NA,"numeric","q25","120.75"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Prior observation",NA,"numeric","median","2082"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Prior observation",NA,"numeric","q75","3053.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Prior observation",NA,"numeric","q95","4548.6"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Prior observation",NA,"numeric","max","5787"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Prior observation",NA,"numeric","mean","1865.13709677419"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Prior observation",NA,"numeric","sd","1610.68899227385"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Future observation",NA,"numeric","min","63"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Future observation",NA,"numeric","q05","119.3"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Future observation",NA,"numeric","q25","748.25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Future observation",NA,"numeric","median","1954.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Future observation",NA,"numeric","q75","3560"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Future observation",NA,"numeric","q95","4283.35"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Future observation",NA,"numeric","max","4395"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Future observation",NA,"numeric","mean","2093.51612903226"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Future observation",NA,"numeric","sd","1469.94331777158"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Comorbidities flag from -365 to 0","Cirrhosis","binary","count","19"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Comorbidities flag from -365 to 0","Cirrhosis","binary","percentage","15.3225806451613"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Comorbidities flag from -365 to 0","Cardiodisorder","binary","count","45"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Comorbidities flag from -365 to 0","Cardiodisorder","binary","percentage","36.2903225806452"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Comorbidities flag from -365 to 0","Alcoholism","binary","count","11"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Comorbidities flag from -365 to 0","Alcoholism","binary","percentage","8.87096774193548"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Comorbidities flag from -365 to 0","Stds","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Comorbidities flag from -365 to 0","Stds","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Comorbidities flag from -365 to 0","Hypertension","binary","count","23"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Comorbidities flag from -365 to 0","Hypertension","binary","percentage","18.5483870967742"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Comorbidities flag from -365 to 0","Hiv","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Comorbidities flag from -365 to 0","Hiv","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Comorbidities flag from -365 to 0","Kidneydisease","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Comorbidities flag from -365 to 0","Kidneydisease","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Comorbidities flag from -365 to 0","Diabetes","binary","count","14"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Comorbidities flag from -365 to 0","Diabetes","binary","percentage","11.2903225806452"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Comorbidities flag from -365 to 0","Fattyliver","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","45 to 64","Comorbidities flag from -365 to 0","Fattyliver","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Number subjects",NA,"numeric","count","52"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Number records",NA,NA,"count","52"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Cohort start date",NA,"date","min","2012-05-03"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Cohort start date",NA,"date","q05","2012-06-07"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Cohort start date",NA,"date","q25","2014-09-11"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Cohort start date",NA,"date","median","2016-06-08"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Cohort start date",NA,"date","q75","2018-02-14"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Cohort start date",NA,"date","q95","2021-08-02"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Cohort start date",NA,"date","max","2022-07-31"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Cohort end date",NA,"date","min","2013-03-19"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Cohort end date",NA,"date","q05","2014-07-27"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Cohort end date",NA,"date","q25","2018-11-03"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Cohort end date",NA,"date","median","2021-08-13"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Cohort end date",NA,"date","q75","2023-08-23"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Cohort end date",NA,"date","q95","2024-01-14"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Cohort end date",NA,"date","max","2024-01-16"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Sex","Female","categorical","count","10"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Sex","Female","categorical","percentage","19.2307692307692"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Sex","Male","categorical","count","42"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Sex","Male","categorical","percentage","80.7692307692308"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Age",NA,"numeric","min","65"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Age",NA,"numeric","q05","65"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Age",NA,"numeric","q25","67"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Age",NA,"numeric","median","70"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Age",NA,"numeric","q75","74.25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Age",NA,"numeric","q95","82.9"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Age",NA,"numeric","max","91"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Age",NA,"numeric","mean","71.5576923076923"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Age",NA,"numeric","sd","5.75790492105763"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Prior observation",NA,"numeric","min","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Prior observation",NA,"numeric","q05","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Prior observation",NA,"numeric","q25","143.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Prior observation",NA,"numeric","median","2396"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Prior observation",NA,"numeric","q75","3786"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Prior observation",NA,"numeric","q95","5284.95"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Prior observation",NA,"numeric","max","5866"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Prior observation",NA,"numeric","mean","2221.09615384615"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Prior observation",NA,"numeric","sd","1827.63036615149"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Future observation",NA,"numeric","min","90"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Future observation",NA,"numeric","q05","121.1"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Future observation",NA,"numeric","q25","573.75"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Future observation",NA,"numeric","median","1206"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Future observation",NA,"numeric","q75","2305.25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Future observation",NA,"numeric","q95","3435.2"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Future observation",NA,"numeric","max","3912"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Future observation",NA,"numeric","mean","1507.19230769231"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Future observation",NA,"numeric","sd","1109.71464338522"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Comorbidities flag from -365 to 0","Cirrhosis","binary","count","7"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Comorbidities flag from -365 to 0","Cirrhosis","binary","percentage","13.4615384615385"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Comorbidities flag from -365 to 0","Cardiodisorder","binary","count","21"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Comorbidities flag from -365 to 0","Cardiodisorder","binary","percentage","40.3846153846154"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Comorbidities flag from -365 to 0","Alcoholism","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Comorbidities flag from -365 to 0","Alcoholism","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Comorbidities flag from -365 to 0","Stds","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Comorbidities flag from -365 to 0","Stds","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Comorbidities flag from -365 to 0","Hypertension","binary","count","11"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Comorbidities flag from -365 to 0","Hypertension","binary","percentage","21.1538461538462"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Comorbidities flag from -365 to 0","Hiv","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Comorbidities flag from -365 to 0","Hiv","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Comorbidities flag from -365 to 0","Kidneydisease","binary","count","5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Comorbidities flag from -365 to 0","Kidneydisease","binary","percentage","9.61538461538461"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Comorbidities flag from -365 to 0","Diabetes","binary","count","9"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Comorbidities flag from -365 to 0","Diabetes","binary","percentage","17.3076923076923"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Comorbidities flag from -365 to 0","Fattyliver","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","age_group","65 to 150","Comorbidities flag from -365 to 0","Fattyliver","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Number subjects",NA,"numeric","count","69"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Number records",NA,NA,"count","69"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Cohort start date",NA,"date","min","2012-01-12"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Cohort start date",NA,"date","q05","2012-02-08"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Cohort start date",NA,"date","q25","2013-04-18"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Cohort start date",NA,"date","median","2014-10-03"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Cohort start date",NA,"date","q75","2016-11-17"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Cohort start date",NA,"date","q95","2019-08-07"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Cohort start date",NA,"date","max","2021-03-28"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Cohort end date",NA,"date","min","2012-07-07"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Cohort end date",NA,"date","q05","2016-03-24"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Cohort end date",NA,"date","q25","2021-03-01"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Cohort end date",NA,"date","median","2023-08-19"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Cohort end date",NA,"date","q75","2023-11-28"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Cohort end date",NA,"date","q95","2024-01-07"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Cohort end date",NA,"date","max","2024-01-16"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Sex","Female","categorical","count","69"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Sex","Female","categorical","percentage","100"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Sex","Male","categorical","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Sex","Male","categorical","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Age",NA,"numeric","min","20"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Age",NA,"numeric","q05","26"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Age",NA,"numeric","q25","41"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Age",NA,"numeric","median","50"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Age",NA,"numeric","q75","60"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Age",NA,"numeric","q95","73.4"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Age",NA,"numeric","max","85"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Age",NA,"numeric","mean","50.463768115942"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Age",NA,"numeric","sd","14.5870406930513"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Prior observation",NA,"numeric","min","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Prior observation",NA,"numeric","q05","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Prior observation",NA,"numeric","q25","123"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Prior observation",NA,"numeric","median","1693"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Prior observation",NA,"numeric","q75","2514"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Prior observation",NA,"numeric","q95","4485.2"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Prior observation",NA,"numeric","max","5787"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Prior observation",NA,"numeric","mean","1662.85507246377"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Prior observation",NA,"numeric","sd","1502.29681287728"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Future observation",NA,"numeric","min","78"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Future observation",NA,"numeric","q05","241.8"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Future observation",NA,"numeric","q25","1409"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Future observation",NA,"numeric","median","2707"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Future observation",NA,"numeric","q75","3625"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Future observation",NA,"numeric","q95","4277"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Future observation",NA,"numeric","max","4363"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Future observation",NA,"numeric","mean","2532.13043478261"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Future observation",NA,"numeric","sd","1311.57270787048"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Comorbidities flag from -365 to 0","Cirrhosis","binary","count","5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Comorbidities flag from -365 to 0","Cirrhosis","binary","percentage","7.2463768115942"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Comorbidities flag from -365 to 0","Cardiodisorder","binary","count","20"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Comorbidities flag from -365 to 0","Cardiodisorder","binary","percentage","28.9855072463768"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Comorbidities flag from -365 to 0","Alcoholism","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Comorbidities flag from -365 to 0","Alcoholism","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Comorbidities flag from -365 to 0","Stds","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Comorbidities flag from -365 to 0","Stds","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Comorbidities flag from -365 to 0","Hypertension","binary","count","12"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Comorbidities flag from -365 to 0","Hypertension","binary","percentage","17.3913043478261"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Comorbidities flag from -365 to 0","Hiv","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Comorbidities flag from -365 to 0","Hiv","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Comorbidities flag from -365 to 0","Kidneydisease","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Comorbidities flag from -365 to 0","Kidneydisease","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Comorbidities flag from -365 to 0","Diabetes","binary","count","7"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Comorbidities flag from -365 to 0","Diabetes","binary","percentage","10.1449275362319"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Comorbidities flag from -365 to 0","Fattyliver","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Female","Comorbidities flag from -365 to 0","Fattyliver","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Number subjects",NA,"numeric","count","166"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Number records",NA,NA,"count","166"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Cohort start date",NA,"date","min","2012-01-04"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Cohort start date",NA,"date","q05","2012-02-11"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Cohort start date",NA,"date","q25","2013-01-19"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Cohort start date",NA,"date","median","2015-01-11"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Cohort start date",NA,"date","q75","2017-02-04"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Cohort start date",NA,"date","q95","2021-04-25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Cohort start date",NA,"date","max","2022-10-18"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Cohort end date",NA,"date","min","2012-09-08"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Cohort end date",NA,"date","q05","2013-12-11"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Cohort end date",NA,"date","q25","2017-04-07"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Cohort end date",NA,"date","median","2021-10-30"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Cohort end date",NA,"date","q75","2023-11-11"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Cohort end date",NA,"date","q95","2024-01-13"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Cohort end date",NA,"date","max","2024-01-16"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Sex","Female","categorical","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Sex","Female","categorical","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Sex","Male","categorical","count","166"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Sex","Male","categorical","percentage","100"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Age",NA,"numeric","min","18"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Age",NA,"numeric","q05","30"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Age",NA,"numeric","q25","45"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Age",NA,"numeric","median","53.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Age",NA,"numeric","q75","64.75"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Age",NA,"numeric","q95","74.75"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Age",NA,"numeric","max","91"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Age",NA,"numeric","mean","53.7289156626506"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Age",NA,"numeric","sd","14.0105590494346"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Prior observation",NA,"numeric","min","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Prior observation",NA,"numeric","q05","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Prior observation",NA,"numeric","q25","83.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Prior observation",NA,"numeric","median","1922.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Prior observation",NA,"numeric","q75","3062.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Prior observation",NA,"numeric","q95","4593"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Prior observation",NA,"numeric","max","5866"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Prior observation",NA,"numeric","mean","1872.01204819277"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Prior observation",NA,"numeric","sd","1664.48566261956"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Future observation",NA,"numeric","min","63"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Future observation",NA,"numeric","q05","119.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Future observation",NA,"numeric","q25","574.25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Future observation",NA,"numeric","median","1628"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Future observation",NA,"numeric","q75","2843.75"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Future observation",NA,"numeric","q95","4216.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Future observation",NA,"numeric","max","4395"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Future observation",NA,"numeric","mean","1860.8734939759"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Future observation",NA,"numeric","sd","1389.63230877675"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Comorbidities flag from -365 to 0","Cirrhosis","binary","count","24"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Comorbidities flag from -365 to 0","Cirrhosis","binary","percentage","14.4578313253012"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Comorbidities flag from -365 to 0","Cardiodisorder","binary","count","56"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Comorbidities flag from -365 to 0","Cardiodisorder","binary","percentage","33.7349397590361"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Comorbidities flag from -365 to 0","Alcoholism","binary","count","15"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Comorbidities flag from -365 to 0","Alcoholism","binary","percentage","9.03614457831325"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Comorbidities flag from -365 to 0","Stds","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Comorbidities flag from -365 to 0","Stds","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Comorbidities flag from -365 to 0","Hypertension","binary","count","23"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Comorbidities flag from -365 to 0","Hypertension","binary","percentage","13.855421686747"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Comorbidities flag from -365 to 0","Hiv","binary","count","8"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Comorbidities flag from -365 to 0","Hiv","binary","percentage","4.81927710843374"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Comorbidities flag from -365 to 0","Kidneydisease","binary","count","5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Comorbidities flag from -365 to 0","Kidneydisease","binary","percentage","3.01204819277108"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Comorbidities flag from -365 to 0","Diabetes","binary","count","18"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Comorbidities flag from -365 to 0","Diabetes","binary","percentage","10.8433734939759"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Comorbidities flag from -365 to 0","Fattyliver","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","sex","Male","Comorbidities flag from -365 to 0","Fattyliver","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Number subjects",NA,"numeric","count","56"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Number records",NA,NA,"count","56"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Cohort start date",NA,"date","min","2012-01-04"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Cohort start date",NA,"date","q05","2012-01-11"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Cohort start date",NA,"date","q25","2012-02-24"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Cohort start date",NA,"date","median","2012-05-16"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Cohort start date",NA,"date","q75","2012-07-31"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Cohort start date",NA,"date","q95","2012-11-06"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Cohort start date",NA,"date","max","2012-11-25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Cohort end date",NA,"date","min","2012-07-07"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Cohort end date",NA,"date","q05","2013-01-20"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Cohort end date",NA,"date","q25","2016-07-02"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Cohort end date",NA,"date","median","2023-04-23"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Cohort end date",NA,"date","q75","2023-12-03"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Cohort end date",NA,"date","q95","2024-01-16"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Cohort end date",NA,"date","max","2024-01-16"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Sex","Female","categorical","count","16"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Sex","Female","categorical","percentage","28.5714285714286"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Sex","Male","categorical","count","40"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Sex","Male","categorical","percentage","71.4285714285714"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Age",NA,"numeric","min","18"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Age",NA,"numeric","q05","26.75"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Age",NA,"numeric","q25","39.75"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Age",NA,"numeric","median","49.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Age",NA,"numeric","q75","57.25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Age",NA,"numeric","q95","77.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Age",NA,"numeric","max","82"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Age",NA,"numeric","mean","49.3571428571429"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Age",NA,"numeric","sd","14.2923101656146"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Prior observation",NA,"numeric","min","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Prior observation",NA,"numeric","q05","11.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Prior observation",NA,"numeric","q25","284.25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Prior observation",NA,"numeric","median","2144"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Prior observation",NA,"numeric","q75","2560"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Prior observation",NA,"numeric","q95","2698.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Prior observation",NA,"numeric","max","2744"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Prior observation",NA,"numeric","mean","1616.48214285714"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Prior observation",NA,"numeric","sd","1079.53527023221"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Future observation",NA,"numeric","min","67"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Future observation",NA,"numeric","q05","162"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Future observation",NA,"numeric","q25","1495.25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Future observation",NA,"numeric","median","3958.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Future observation",NA,"numeric","q75","4213.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Future observation",NA,"numeric","q95","4368"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Future observation",NA,"numeric","max","4395"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Future observation",NA,"numeric","mean","2944.16071428571"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Future observation",NA,"numeric","sd","1607.8422896064"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Comorbidities flag from -365 to 0","Cirrhosis","binary","count","6"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Comorbidities flag from -365 to 0","Cirrhosis","binary","percentage","10.7142857142857"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Comorbidities flag from -365 to 0","Cardiodisorder","binary","count","13"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Comorbidities flag from -365 to 0","Cardiodisorder","binary","percentage","23.2142857142857"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Comorbidities flag from -365 to 0","Alcoholism","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Comorbidities flag from -365 to 0","Alcoholism","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Comorbidities flag from -365 to 0","Stds","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Comorbidities flag from -365 to 0","Stds","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Comorbidities flag from -365 to 0","Hypertension","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Comorbidities flag from -365 to 0","Hypertension","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Comorbidities flag from -365 to 0","Hiv","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Comorbidities flag from -365 to 0","Hiv","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Comorbidities flag from -365 to 0","Kidneydisease","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Comorbidities flag from -365 to 0","Kidneydisease","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Comorbidities flag from -365 to 0","Diabetes","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Comorbidities flag from -365 to 0","Diabetes","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Comorbidities flag from -365 to 0","Fattyliver","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2012","Comorbidities flag from -365 to 0","Fattyliver","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Number subjects",NA,"numeric","count","34"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Number records",NA,NA,"count","34"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Cohort start date",NA,"date","min","2013-01-17"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Cohort start date",NA,"date","q05","2013-01-18"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Cohort start date",NA,"date","q25","2013-03-08"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Cohort start date",NA,"date","median","2013-06-12"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Cohort start date",NA,"date","q75","2013-09-14"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Cohort start date",NA,"date","q95","2013-12-12"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Cohort start date",NA,"date","max","2013-12-20"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Cohort end date",NA,"date","min","2013-06-21"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Cohort end date",NA,"date","q05","2013-10-20"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Cohort end date",NA,"date","q25","2016-07-20"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Cohort end date",NA,"date","median","2021-09-28"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Cohort end date",NA,"date","q75","2023-11-06"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Cohort end date",NA,"date","q95","2024-01-05"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Cohort end date",NA,"date","max","2024-01-16"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Sex","Female","categorical","count","9"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Sex","Female","categorical","percentage","26.4705882352941"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Sex","Male","categorical","count","25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Sex","Male","categorical","percentage","73.5294117647059"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Age",NA,"numeric","min","32"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Age",NA,"numeric","q05","39.65"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Age",NA,"numeric","q25","47"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Age",NA,"numeric","median","51"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Age",NA,"numeric","q75","57.75"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Age",NA,"numeric","q95","65"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Age",NA,"numeric","max","65"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Age",NA,"numeric","mean","51.7647058823529"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Age",NA,"numeric","sd","8.33051645795913"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Prior observation",NA,"numeric","min","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Prior observation",NA,"numeric","q05","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Prior observation",NA,"numeric","q25","41.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Prior observation",NA,"numeric","median","832.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Prior observation",NA,"numeric","q75","2927.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Prior observation",NA,"numeric","q95","3141.75"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Prior observation",NA,"numeric","max","3244"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Prior observation",NA,"numeric","mean","1438.41176470588"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Prior observation",NA,"numeric","sd","1408.45462524447"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Future observation",NA,"numeric","min","71"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Future observation",NA,"numeric","q05","107.7"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Future observation",NA,"numeric","q25","1093"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Future observation",NA,"numeric","median","2881.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Future observation",NA,"numeric","q75","3844.25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Future observation",NA,"numeric","q95","3963.95"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Future observation",NA,"numeric","max","4001"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Future observation",NA,"numeric","mean","2450.35294117647"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Future observation",NA,"numeric","sd","1461.61035893795"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Comorbidities flag from -365 to 0","Cirrhosis","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Comorbidities flag from -365 to 0","Cirrhosis","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Comorbidities flag from -365 to 0","Cardiodisorder","binary","count","14"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Comorbidities flag from -365 to 0","Cardiodisorder","binary","percentage","41.1764705882353"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Comorbidities flag from -365 to 0","Alcoholism","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Comorbidities flag from -365 to 0","Alcoholism","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Comorbidities flag from -365 to 0","Stds","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Comorbidities flag from -365 to 0","Stds","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Comorbidities flag from -365 to 0","Hypertension","binary","count","6"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Comorbidities flag from -365 to 0","Hypertension","binary","percentage","17.6470588235294"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Comorbidities flag from -365 to 0","Hiv","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Comorbidities flag from -365 to 0","Hiv","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Comorbidities flag from -365 to 0","Kidneydisease","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Comorbidities flag from -365 to 0","Kidneydisease","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Comorbidities flag from -365 to 0","Diabetes","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Comorbidities flag from -365 to 0","Diabetes","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Comorbidities flag from -365 to 0","Fattyliver","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2013","Comorbidities flag from -365 to 0","Fattyliver","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Number subjects",NA,"numeric","count","28"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Number records",NA,NA,"count","28"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Cohort start date",NA,"date","min","2014-01-07"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Cohort start date",NA,"date","q05","2014-01-13"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Cohort start date",NA,"date","q25","2014-02-19"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Cohort start date",NA,"date","median","2014-05-15"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Cohort start date",NA,"date","q75","2014-08-30"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Cohort start date",NA,"date","q95","2014-11-01"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Cohort start date",NA,"date","max","2014-11-25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Cohort end date",NA,"date","min","2014-10-11"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Cohort end date",NA,"date","q05","2014-12-22"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Cohort end date",NA,"date","q25","2017-08-23"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Cohort end date",NA,"date","median","2022-08-18"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Cohort end date",NA,"date","q75","2023-09-20"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Cohort end date",NA,"date","q95","2024-01-07"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Cohort end date",NA,"date","max","2024-01-13"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Sex","Female","categorical","count","11"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Sex","Female","categorical","percentage","39.2857142857143"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Sex","Male","categorical","count","17"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Sex","Male","categorical","percentage","60.7142857142857"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Age",NA,"numeric","min","23"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Age",NA,"numeric","q05","24.35"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Age",NA,"numeric","q25","34"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Age",NA,"numeric","median","51.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Age",NA,"numeric","q75","60.25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Age",NA,"numeric","q95","67.65"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Age",NA,"numeric","max","68"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Age",NA,"numeric","mean","48.75"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Age",NA,"numeric","sd","15.0348360914343"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Prior observation",NA,"numeric","min","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Prior observation",NA,"numeric","q05","4.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Prior observation",NA,"numeric","q25","106.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Prior observation",NA,"numeric","median","1511"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Prior observation",NA,"numeric","q75","2387.75"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Prior observation",NA,"numeric","q95","3275.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Prior observation",NA,"numeric","max","3352"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Prior observation",NA,"numeric","mean","1474.85714285714"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Prior observation",NA,"numeric","sd","1201.08536453911"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Future observation",NA,"numeric","min","83"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Future observation",NA,"numeric","q05","147.2"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Future observation",NA,"numeric","q25","1270.75"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Future observation",NA,"numeric","median","3134.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Future observation",NA,"numeric","q75","3354"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Future observation",NA,"numeric","q95","3561.6"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Future observation",NA,"numeric","max","3625"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Future observation",NA,"numeric","mean","2342.85714285714"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Future observation",NA,"numeric","sd","1265.72437799791"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Comorbidities flag from -365 to 0","Cirrhosis","binary","count","6"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Comorbidities flag from -365 to 0","Cirrhosis","binary","percentage","21.4285714285714"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Comorbidities flag from -365 to 0","Cardiodisorder","binary","count","8"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Comorbidities flag from -365 to 0","Cardiodisorder","binary","percentage","28.5714285714286"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Comorbidities flag from -365 to 0","Alcoholism","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Comorbidities flag from -365 to 0","Alcoholism","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Comorbidities flag from -365 to 0","Stds","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Comorbidities flag from -365 to 0","Stds","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Comorbidities flag from -365 to 0","Hypertension","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Comorbidities flag from -365 to 0","Hypertension","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Comorbidities flag from -365 to 0","Hiv","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Comorbidities flag from -365 to 0","Hiv","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Comorbidities flag from -365 to 0","Kidneydisease","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Comorbidities flag from -365 to 0","Kidneydisease","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Comorbidities flag from -365 to 0","Diabetes","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Comorbidities flag from -365 to 0","Diabetes","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Comorbidities flag from -365 to 0","Fattyliver","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2014","Comorbidities flag from -365 to 0","Fattyliver","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Number subjects",NA,"numeric","count","24"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Number records",NA,NA,"count","24"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Cohort start date",NA,"date","min","2015-01-08"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Cohort start date",NA,"date","q05","2015-01-17"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Cohort start date",NA,"date","q25","2015-04-21"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Cohort start date",NA,"date","median","2015-07-18"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Cohort start date",NA,"date","q75","2015-09-01"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Cohort start date",NA,"date","q95","2015-11-07"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Cohort start date",NA,"date","max","2015-11-23"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Cohort end date",NA,"date","min","2015-06-02"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Cohort end date",NA,"date","q05","2016-01-18"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Cohort end date",NA,"date","q25","2016-06-15"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Cohort end date",NA,"date","median","2019-10-01"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Cohort end date",NA,"date","q75","2023-09-17"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Cohort end date",NA,"date","q95","2024-01-07"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Cohort end date",NA,"date","max","2024-01-16"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Sex","Female","categorical","count","9"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Sex","Female","categorical","percentage","37.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Sex","Male","categorical","count","15"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Sex","Male","categorical","percentage","62.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Age",NA,"numeric","min","26"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Age",NA,"numeric","q05","29.15"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Age",NA,"numeric","q25","41.75"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Age",NA,"numeric","median","50.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Age",NA,"numeric","q75","65.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Age",NA,"numeric","q95","78.4"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Age",NA,"numeric","max","79"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Age",NA,"numeric","mean","53.4583333333333"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Age",NA,"numeric","sd","16.3387487325354"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Prior observation",NA,"numeric","min","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Prior observation",NA,"numeric","q05","1.45"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Prior observation",NA,"numeric","q25","59.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Prior observation",NA,"numeric","median","2019.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Prior observation",NA,"numeric","q75","3626.25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Prior observation",NA,"numeric","q95","3897.25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Prior observation",NA,"numeric","max","3931"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Prior observation",NA,"numeric","mean","2044.75"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Prior observation",NA,"numeric","sd","1633.30612296175"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Future observation",NA,"numeric","min","63"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Future observation",NA,"numeric","q05","95.7"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Future observation",NA,"numeric","q25","370.25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Future observation",NA,"numeric","median","1496.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Future observation",NA,"numeric","q75","2933.75"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Future observation",NA,"numeric","q95","3113.2"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Future observation",NA,"numeric","max","3174"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Future observation",NA,"numeric","mean","1692.875"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Future observation",NA,"numeric","sd","1249.01712010058"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Comorbidities flag from -365 to 0","Cirrhosis","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Comorbidities flag from -365 to 0","Cirrhosis","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Comorbidities flag from -365 to 0","Cardiodisorder","binary","count","6"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Comorbidities flag from -365 to 0","Cardiodisorder","binary","percentage","25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Comorbidities flag from -365 to 0","Alcoholism","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Comorbidities flag from -365 to 0","Alcoholism","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Comorbidities flag from -365 to 0","Stds","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Comorbidities flag from -365 to 0","Stds","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Comorbidities flag from -365 to 0","Hypertension","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Comorbidities flag from -365 to 0","Hypertension","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Comorbidities flag from -365 to 0","Hiv","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Comorbidities flag from -365 to 0","Hiv","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Comorbidities flag from -365 to 0","Kidneydisease","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Comorbidities flag from -365 to 0","Kidneydisease","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Comorbidities flag from -365 to 0","Diabetes","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Comorbidities flag from -365 to 0","Diabetes","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Comorbidities flag from -365 to 0","Fattyliver","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2015","Comorbidities flag from -365 to 0","Fattyliver","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Number subjects",NA,"numeric","count","33"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Number records",NA,NA,"count","33"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Cohort start date",NA,"date","min","2016-01-10"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Cohort start date",NA,"date","q05","2016-01-16"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Cohort start date",NA,"date","q25","2016-02-25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Cohort start date",NA,"date","median","2016-05-24"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Cohort start date",NA,"date","q75","2016-09-07"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Cohort start date",NA,"date","q95","2016-11-12"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Cohort start date",NA,"date","max","2016-12-01"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Cohort end date",NA,"date","min","2016-07-29"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Cohort end date",NA,"date","q05","2016-09-11"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Cohort end date",NA,"date","q25","2018-11-02"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Cohort end date",NA,"date","median","2021-04-18"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Cohort end date",NA,"date","q75","2023-07-21"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Cohort end date",NA,"date","q95","2023-12-17"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Cohort end date",NA,"date","max","2023-12-30"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Sex","Female","categorical","count","7"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Sex","Female","categorical","percentage","21.2121212121212"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Sex","Male","categorical","count","26"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Sex","Male","categorical","percentage","78.7878787878788"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Age",NA,"numeric","min","25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Age",NA,"numeric","q05","28.4"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Age",NA,"numeric","q25","46"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Age",NA,"numeric","median","59"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Age",NA,"numeric","q75","68"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Age",NA,"numeric","q95","77.4"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Age",NA,"numeric","max","91"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Age",NA,"numeric","mean","55.4848484848485"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Age",NA,"numeric","sd","16.3976393349035"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Prior observation",NA,"numeric","min","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Prior observation",NA,"numeric","q05","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Prior observation",NA,"numeric","q25","241"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Prior observation",NA,"numeric","median","2200"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Prior observation",NA,"numeric","q75","3835"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Prior observation",NA,"numeric","q95","4055"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Prior observation",NA,"numeric","max","4159"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Prior observation",NA,"numeric","mean","1981.48484848485"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Prior observation",NA,"numeric","sd","1696.70213431108"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Future observation",NA,"numeric","min","67"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Future observation",NA,"numeric","q05","124.4"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Future observation",NA,"numeric","q25","866"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Future observation",NA,"numeric","median","1760"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Future observation",NA,"numeric","q75","2556"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Future observation",NA,"numeric","q95","2773.6"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Future observation",NA,"numeric","max","2861"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Future observation",NA,"numeric","mean","1601"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Future observation",NA,"numeric","sd","997.708656121615"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Comorbidities flag from -365 to 0","Cirrhosis","binary","count","6"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Comorbidities flag from -365 to 0","Cirrhosis","binary","percentage","18.1818181818182"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Comorbidities flag from -365 to 0","Cardiodisorder","binary","count","12"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Comorbidities flag from -365 to 0","Cardiodisorder","binary","percentage","36.3636363636364"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Comorbidities flag from -365 to 0","Alcoholism","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Comorbidities flag from -365 to 0","Alcoholism","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Comorbidities flag from -365 to 0","Stds","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Comorbidities flag from -365 to 0","Stds","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Comorbidities flag from -365 to 0","Hypertension","binary","count","5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Comorbidities flag from -365 to 0","Hypertension","binary","percentage","15.1515151515152"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Comorbidities flag from -365 to 0","Hiv","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Comorbidities flag from -365 to 0","Hiv","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Comorbidities flag from -365 to 0","Kidneydisease","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Comorbidities flag from -365 to 0","Kidneydisease","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Comorbidities flag from -365 to 0","Diabetes","binary","count","5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Comorbidities flag from -365 to 0","Diabetes","binary","percentage","15.1515151515152"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Comorbidities flag from -365 to 0","Fattyliver","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2016","Comorbidities flag from -365 to 0","Fattyliver","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Number subjects",NA,"numeric","count","25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Number records",NA,NA,"count","25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Cohort start date",NA,"date","min","2017-01-04"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Cohort start date",NA,"date","q05","2017-01-13"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Cohort start date",NA,"date","q25","2017-03-06"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Cohort start date",NA,"date","median","2017-06-09"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Cohort start date",NA,"date","q75","2017-09-26"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Cohort start date",NA,"date","q95","2017-11-20"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Cohort start date",NA,"date","max","2017-12-11"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Cohort end date",NA,"date","min","2017-05-15"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Cohort end date",NA,"date","q05","2018-01-26"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Cohort end date",NA,"date","q25","2019-09-15"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Cohort end date",NA,"date","median","2023-07-29"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Cohort end date",NA,"date","q75","2023-12-18"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Cohort end date",NA,"date","q95","2024-01-05"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Cohort end date",NA,"date","max","2024-01-16"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Sex","Female","categorical","count","7"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Sex","Female","categorical","percentage","28"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Sex","Male","categorical","count","18"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Sex","Male","categorical","percentage","72"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Age",NA,"numeric","min","28"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Age",NA,"numeric","q05","30.6"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Age",NA,"numeric","q25","41"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Age",NA,"numeric","median","56"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Age",NA,"numeric","q75","66"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Age",NA,"numeric","q95","76.2"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Age",NA,"numeric","max","77"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Age",NA,"numeric","mean","53.64"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Age",NA,"numeric","sd","15.2202715700695"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Prior observation",NA,"numeric","min","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Prior observation",NA,"numeric","q05","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Prior observation",NA,"numeric","q25","96"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Prior observation",NA,"numeric","median","1045"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Prior observation",NA,"numeric","q75","4149"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Prior observation",NA,"numeric","q95","4581.6"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Prior observation",NA,"numeric","max","4640"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Prior observation",NA,"numeric","mean","1895.08"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Prior observation",NA,"numeric","sd","1951.0716696216"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Future observation",NA,"numeric","min","90"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Future observation",NA,"numeric","q05","172"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Future observation",NA,"numeric","q25","880"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Future observation",NA,"numeric","median","2195"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Future observation",NA,"numeric","q75","2305"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Future observation",NA,"numeric","q95","2442.8"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Future observation",NA,"numeric","max","2513"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Future observation",NA,"numeric","mean","1663.04"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Future observation",NA,"numeric","sd","864.687876249768"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Comorbidities flag from -365 to 0","Cirrhosis","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Comorbidities flag from -365 to 0","Cirrhosis","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Comorbidities flag from -365 to 0","Cardiodisorder","binary","count","11"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Comorbidities flag from -365 to 0","Cardiodisorder","binary","percentage","44"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Comorbidities flag from -365 to 0","Alcoholism","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Comorbidities flag from -365 to 0","Alcoholism","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Comorbidities flag from -365 to 0","Stds","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Comorbidities flag from -365 to 0","Stds","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Comorbidities flag from -365 to 0","Hypertension","binary","count","7"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Comorbidities flag from -365 to 0","Hypertension","binary","percentage","28"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Comorbidities flag from -365 to 0","Hiv","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Comorbidities flag from -365 to 0","Hiv","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Comorbidities flag from -365 to 0","Kidneydisease","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Comorbidities flag from -365 to 0","Kidneydisease","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Comorbidities flag from -365 to 0","Diabetes","binary","count","6"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Comorbidities flag from -365 to 0","Diabetes","binary","percentage","24"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Comorbidities flag from -365 to 0","Fattyliver","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2017","Comorbidities flag from -365 to 0","Fattyliver","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Number subjects",NA,"numeric","count","7"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Number records",NA,NA,"count","7"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Cohort start date",NA,"date","min","2018-01-09"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Cohort start date",NA,"date","q05","2018-01-18"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Cohort start date",NA,"date","q25","2018-02-20"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Cohort start date",NA,"date","median","2018-06-04"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Cohort start date",NA,"date","q75","2018-07-12"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Cohort start date",NA,"date","q95","2018-08-13"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Cohort start date",NA,"date","max","2018-08-22"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Cohort end date",NA,"date","min","2020-02-21"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Cohort end date",NA,"date","q05","2020-05-26"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Cohort end date",NA,"date","q25","2021-02-20"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Cohort end date",NA,"date","median","2023-08-19"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Cohort end date",NA,"date","q75","2023-11-25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Cohort end date",NA,"date","q95","2023-12-23"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Cohort end date",NA,"date","max","2024-01-01"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Sex","Female","categorical","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Sex","Female","categorical","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Sex","Male","categorical","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Sex","Male","categorical","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Age",NA,"numeric","min","39"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Age",NA,"numeric","q05","40.8"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Age",NA,"numeric","q25","50"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Age",NA,"numeric","median","64"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Age",NA,"numeric","q75","66.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Age",NA,"numeric","q95","79.6"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Age",NA,"numeric","max","85"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Age",NA,"numeric","mean","60.1428571428571"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Age",NA,"numeric","sd","15.3669403962811"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Prior observation",NA,"numeric","min","3"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Prior observation",NA,"numeric","q05","3.3"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Prior observation",NA,"numeric","q25","4.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Prior observation",NA,"numeric","median","568"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Prior observation",NA,"numeric","q75","2260.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Prior observation",NA,"numeric","q95","3931.3"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Prior observation",NA,"numeric","max","4603"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Prior observation",NA,"numeric","mean","1386.28571428571"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Prior observation",NA,"numeric","sd","1746.37297603592"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Future observation",NA,"numeric","min","719"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Future observation",NA,"numeric","q05","786.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Future observation",NA,"numeric","q25","967.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Future observation",NA,"numeric","median","1874"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Future observation",NA,"numeric","q75","2019"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Future observation",NA,"numeric","q95","2161.4"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Future observation",NA,"numeric","max","2183"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Future observation",NA,"numeric","mean","1535.57142857143"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Future observation",NA,"numeric","sd","623.342564230097"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Comorbidities flag from -365 to 0","Cirrhosis","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Comorbidities flag from -365 to 0","Cirrhosis","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Comorbidities flag from -365 to 0","Cardiodisorder","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Comorbidities flag from -365 to 0","Cardiodisorder","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Comorbidities flag from -365 to 0","Alcoholism","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Comorbidities flag from -365 to 0","Alcoholism","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Comorbidities flag from -365 to 0","Stds","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Comorbidities flag from -365 to 0","Stds","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Comorbidities flag from -365 to 0","Hypertension","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Comorbidities flag from -365 to 0","Hypertension","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Comorbidities flag from -365 to 0","Hiv","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Comorbidities flag from -365 to 0","Hiv","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Comorbidities flag from -365 to 0","Kidneydisease","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Comorbidities flag from -365 to 0","Kidneydisease","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Comorbidities flag from -365 to 0","Diabetes","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Comorbidities flag from -365 to 0","Diabetes","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Comorbidities flag from -365 to 0","Fattyliver","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2018","Comorbidities flag from -365 to 0","Fattyliver","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Number subjects",NA,"numeric","count","10"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Number records",NA,NA,"count","10"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Cohort start date",NA,"date","min","2019-01-31"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Cohort start date",NA,"date","q05","2019-02-15"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Cohort start date",NA,"date","q25","2019-03-31"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Cohort start date",NA,"date","median","2019-06-25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Cohort start date",NA,"date","q75","2019-08-21"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Cohort start date",NA,"date","q95","2019-11-01"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Cohort start date",NA,"date","max","2019-12-13"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Cohort end date",NA,"date","min","2020-07-31"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Cohort end date",NA,"date","q05","2020-09-19"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Cohort end date",NA,"date","q25","2021-01-30"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Cohort end date",NA,"date","median","2023-03-11"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Cohort end date",NA,"date","q75","2023-10-19"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Cohort end date",NA,"date","q95","2023-12-28"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Cohort end date",NA,"date","max","2024-01-01"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Sex","Female","categorical","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Sex","Female","categorical","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Sex","Male","categorical","count","7"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Sex","Male","categorical","percentage","70"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Age",NA,"numeric","min","35"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Age",NA,"numeric","q05","39.95"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Age",NA,"numeric","q25","47.25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Age",NA,"numeric","median","50"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Age",NA,"numeric","q75","53.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Age",NA,"numeric","q95","70.1"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Age",NA,"numeric","max","71"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Age",NA,"numeric","mean","52.2"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Age",NA,"numeric","sd","10.6854002160788"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Prior observation",NA,"numeric","min","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Prior observation",NA,"numeric","q05","2.7"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Prior observation",NA,"numeric","q25","38"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Prior observation",NA,"numeric","median","651"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Prior observation",NA,"numeric","q75","4165.25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Prior observation",NA,"numeric","q95","4919.6"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Prior observation",NA,"numeric","max","5123"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Prior observation",NA,"numeric","mean","1870.1"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Prior observation",NA,"numeric","sd","2203.18110669298"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Future observation",NA,"numeric","min","333"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Future observation",NA,"numeric","q05","405"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Future observation",NA,"numeric","q25","612.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Future observation",NA,"numeric","median","1231"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Future observation",NA,"numeric","q75","1623.25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Future observation",NA,"numeric","q95","1734.2"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Future observation",NA,"numeric","max","1763"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Future observation",NA,"numeric","mean","1129.3"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Future observation",NA,"numeric","sd","550.359286688654"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Comorbidities flag from -365 to 0","Cirrhosis","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Comorbidities flag from -365 to 0","Cirrhosis","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Comorbidities flag from -365 to 0","Cardiodisorder","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Comorbidities flag from -365 to 0","Cardiodisorder","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Comorbidities flag from -365 to 0","Alcoholism","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Comorbidities flag from -365 to 0","Alcoholism","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Comorbidities flag from -365 to 0","Stds","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Comorbidities flag from -365 to 0","Stds","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Comorbidities flag from -365 to 0","Hypertension","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Comorbidities flag from -365 to 0","Hypertension","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Comorbidities flag from -365 to 0","Hiv","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Comorbidities flag from -365 to 0","Hiv","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Comorbidities flag from -365 to 0","Kidneydisease","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Comorbidities flag from -365 to 0","Kidneydisease","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Comorbidities flag from -365 to 0","Diabetes","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Comorbidities flag from -365 to 0","Diabetes","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Comorbidities flag from -365 to 0","Fattyliver","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2019","Comorbidities flag from -365 to 0","Fattyliver","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Number subjects",NA,"numeric","count","5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Number records",NA,NA,"count","5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Cohort start date",NA,"date","min","2020-03-07"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Cohort start date",NA,"date","q05","2020-03-09"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Cohort start date",NA,"date","q25","2020-03-19"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Cohort start date",NA,"date","median","2020-04-11"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Cohort start date",NA,"date","q75","2020-07-07"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Cohort start date",NA,"date","q95","2020-08-04"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Cohort start date",NA,"date","max","2020-08-11"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Cohort end date",NA,"date","min","2020-07-17"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Cohort end date",NA,"date","q05","2020-10-15"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Cohort end date",NA,"date","q25","2021-10-08"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Cohort end date",NA,"date","median","2022-03-07"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Cohort end date",NA,"date","q75","2023-03-03"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Cohort end date",NA,"date","q95","2023-10-03"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Cohort end date",NA,"date","max","2023-11-25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Sex","Female","categorical","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Sex","Female","categorical","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Sex","Male","categorical","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Sex","Male","categorical","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Age",NA,"numeric","min","50"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Age",NA,"numeric","q05","53.2"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Age",NA,"numeric","q25","66"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Age",NA,"numeric","median","67"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Age",NA,"numeric","q75","70"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Age",NA,"numeric","q95","70"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Age",NA,"numeric","max","70"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Age",NA,"numeric","mean","64.6"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Age",NA,"numeric","sd","8.35463942968217"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Prior observation",NA,"numeric","min","1183"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Prior observation",NA,"numeric","q05","1439.6"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Prior observation",NA,"numeric","q25","2466"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Prior observation",NA,"numeric","median","4355"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Prior observation",NA,"numeric","q75","5401"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Prior observation",NA,"numeric","q95","5491.4"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Prior observation",NA,"numeric","max","5514"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Prior observation",NA,"numeric","mean","3783.8"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Prior observation",NA,"numeric","sd","1899.73384978002"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Future observation",NA,"numeric","min","120"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Future observation",NA,"numeric","q05","187.6"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Future observation",NA,"numeric","q25","458"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Future observation",NA,"numeric","median","573"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Future observation",NA,"numeric","q75","1091"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Future observation",NA,"numeric","q95","1276.6"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Future observation",NA,"numeric","max","1323"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Future observation",NA,"numeric","mean","713"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Future observation",NA,"numeric","sd","487.662280682031"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Comorbidities flag from -365 to 0","Cirrhosis","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Comorbidities flag from -365 to 0","Cirrhosis","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Comorbidities flag from -365 to 0","Cardiodisorder","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Comorbidities flag from -365 to 0","Cardiodisorder","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Comorbidities flag from -365 to 0","Alcoholism","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Comorbidities flag from -365 to 0","Alcoholism","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Comorbidities flag from -365 to 0","Stds","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Comorbidities flag from -365 to 0","Stds","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Comorbidities flag from -365 to 0","Hypertension","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Comorbidities flag from -365 to 0","Hypertension","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Comorbidities flag from -365 to 0","Hiv","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Comorbidities flag from -365 to 0","Hiv","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Comorbidities flag from -365 to 0","Kidneydisease","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Comorbidities flag from -365 to 0","Kidneydisease","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Comorbidities flag from -365 to 0","Diabetes","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Comorbidities flag from -365 to 0","Diabetes","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Comorbidities flag from -365 to 0","Fattyliver","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2020","Comorbidities flag from -365 to 0","Fattyliver","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Number subjects",NA,"numeric","count","8"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Number records",NA,NA,"count","8"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Cohort start date",NA,"date","min","2021-01-07"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Cohort start date",NA,"date","q05","2021-01-21"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Cohort start date",NA,"date","q25","2021-03-04"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Cohort start date",NA,"date","median","2021-04-19"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Cohort start date",NA,"date","q75","2021-07-14"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Cohort start date",NA,"date","q95","2021-09-09"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Cohort start date",NA,"date","max","2021-09-14"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Cohort end date",NA,"date","min","2021-10-05"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Cohort end date",NA,"date","q05","2022-06-30"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Cohort end date",NA,"date","q25","2023-11-27"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Cohort end date",NA,"date","median","2023-12-24"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Cohort end date",NA,"date","q75","2024-01-13"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Cohort end date",NA,"date","q95","2024-01-16"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Cohort end date",NA,"date","max","2024-01-16"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Sex","Female","categorical","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Sex","Female","categorical","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Sex","Male","categorical","count","7"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Sex","Male","categorical","percentage","87.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Age",NA,"numeric","min","55"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Age",NA,"numeric","q05","56.4"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Age",NA,"numeric","q25","59"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Age",NA,"numeric","median","61.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Age",NA,"numeric","q75","67.25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Age",NA,"numeric","q95","69.3"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Age",NA,"numeric","max","70"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Age",NA,"numeric","mean","62.625"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Age",NA,"numeric","sd","5.26273964503552"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Prior observation",NA,"numeric","min","24"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Prior observation",NA,"numeric","q05","29.6"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Prior observation",NA,"numeric","q25","40.75"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Prior observation",NA,"numeric","median","2630"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Prior observation",NA,"numeric","q75","5724.75"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Prior observation",NA,"numeric","q95","5838.35"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Prior observation",NA,"numeric","max","5866"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Prior observation",NA,"numeric","mean","2840.25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Prior observation",NA,"numeric","sd","2719.25697571965"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Future observation",NA,"numeric","min","147"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Future observation",NA,"numeric","q05","386.4"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Future observation",NA,"numeric","q25","845.25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Future observation",NA,"numeric","median","974"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Future observation",NA,"numeric","q75","1024.5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Future observation",NA,"numeric","q95","1041.25"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Future observation",NA,"numeric","max","1043"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Future observation",NA,"numeric","mean","859.625"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Future observation",NA,"numeric","sd","299.905193352833"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Comorbidities flag from -365 to 0","Cirrhosis","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Comorbidities flag from -365 to 0","Cirrhosis","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Comorbidities flag from -365 to 0","Cardiodisorder","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Comorbidities flag from -365 to 0","Cardiodisorder","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Comorbidities flag from -365 to 0","Alcoholism","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Comorbidities flag from -365 to 0","Alcoholism","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Comorbidities flag from -365 to 0","Stds","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Comorbidities flag from -365 to 0","Stds","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Comorbidities flag from -365 to 0","Hypertension","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Comorbidities flag from -365 to 0","Hypertension","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Comorbidities flag from -365 to 0","Hiv","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Comorbidities flag from -365 to 0","Hiv","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Comorbidities flag from -365 to 0","Kidneydisease","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Comorbidities flag from -365 to 0","Kidneydisease","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Comorbidities flag from -365 to 0","Diabetes","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Comorbidities flag from -365 to 0","Diabetes","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Comorbidities flag from -365 to 0","Fattyliver","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2021","Comorbidities flag from -365 to 0","Fattyliver","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Number subjects",NA,"numeric","count","5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Number records",NA,NA,"count","5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Cohort start date",NA,"date","min","2022-06-10"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Cohort start date",NA,"date","q05","2022-06-11"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Cohort start date",NA,"date","q25","2022-06-17"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Cohort start date",NA,"date","median","2022-07-31"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Cohort start date",NA,"date","q75","2022-08-29"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Cohort start date",NA,"date","q95","2022-10-08"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Cohort start date",NA,"date","max","2022-10-18"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Cohort end date",NA,"date","min","2023-09-04"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Cohort end date",NA,"date","q05","2023-09-05"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Cohort end date",NA,"date","q25","2023-09-11"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Cohort end date",NA,"date","median","2023-11-10"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Cohort end date",NA,"date","q75","2024-01-06"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Cohort end date",NA,"date","q95","2024-01-11"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Cohort end date",NA,"date","max","2024-01-12"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Sex","Female","categorical","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Sex","Female","categorical","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Sex","Male","categorical","count","5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Sex","Male","categorical","percentage","100"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Age",NA,"numeric","min","31"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Age",NA,"numeric","q05","36.4"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Age",NA,"numeric","q25","58"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Age",NA,"numeric","median","58"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Age",NA,"numeric","q75","68"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Age",NA,"numeric","q95","73.6"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Age",NA,"numeric","max","75"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Age",NA,"numeric","mean","58"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Age",NA,"numeric","sd","16.7182534973005"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Prior observation",NA,"numeric","min","212"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Prior observation",NA,"numeric","q05","265.8"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Prior observation",NA,"numeric","q25","481"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Prior observation",NA,"numeric","median","1488"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Prior observation",NA,"numeric","q75","5190"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Prior observation",NA,"numeric","q95","5445.2"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Prior observation",NA,"numeric","max","5509"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Prior observation",NA,"numeric","mean","2576"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Prior observation",NA,"numeric","sd","2578.60184984034"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Future observation",NA,"numeric","min","328"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Future observation",NA,"numeric","q05","342.4"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Future observation",NA,"numeric","q25","400"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Future observation",NA,"numeric","median","438"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Future observation",NA,"numeric","q75","574"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Future observation",NA,"numeric","q95","574.8"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Future observation",NA,"numeric","max","575"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Future observation",NA,"numeric","mean","463"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Future observation",NA,"numeric","sd","109.183332061263"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Comorbidities flag from -365 to 0","Cirrhosis","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Comorbidities flag from -365 to 0","Cirrhosis","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Comorbidities flag from -365 to 0","Cardiodisorder","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Comorbidities flag from -365 to 0","Cardiodisorder","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Comorbidities flag from -365 to 0","Alcoholism","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Comorbidities flag from -365 to 0","Alcoholism","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Comorbidities flag from -365 to 0","Stds","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Comorbidities flag from -365 to 0","Stds","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Comorbidities flag from -365 to 0","Hypertension","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Comorbidities flag from -365 to 0","Hypertension","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Comorbidities flag from -365 to 0","Hiv","binary","count","<5"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Comorbidities flag from -365 to 0","Hiv","binary","percentage",NA
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Comorbidities flag from -365 to 0","Kidneydisease","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Comorbidities flag from -365 to 0","Kidneydisease","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Comorbidities flag from -365 to 0","Diabetes","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Comorbidities flag from -365 to 0","Diabetes","binary","percentage","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Comorbidities flag from -365 to 0","Fattyliver","binary","count","0"
"omop","summarised_characteristics","cohort_name","Objective3 hepatitisb 2","calendarYear","2022","Comorbidities flag from -365 to 0","Fattyliver","binary","percentage","0"
